Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Pralidoxime Iodide (PAM)
Active Ingredient: Pralidoxime iodide 25mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Abbott Australasia Pty Limited, Kurnell, New South Wales, Australia
Note: This consent is valid for two years from 16 November 2002.
Dated this 28th day of November 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).